Talos (Decision/Risk Analysis) Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 9

Talos (Decision/Risk Analysis) General Information

Description

Developer of an AI-based cerebral aneurysm risk prediction algorithm designed to predict individual risk. The company's algorithm predicts individual risk by dividing it into five levels, lowest-risk group, the low-risk group, average risk group, the high-risk group and the highest-risk group, enabling services to domestic and foreign screening agencies

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 716 Dreamplus, 311, Gangnam-daero
  • Seocho-gu
  • Seoul
  • South Korea
+82
Primary Industry
Decision/Risk Analysis
Corporate Office
  • Number 716 Dreamplus, 311, Gangnam-daero
  • Seocho-gu
  • Seoul
  • South Korea
+82

Talos (Decision/Risk Analysis) Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Talos (Decision/Risk Analysis) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Accelerator/Incubator 01-Jan-2026 Completed Generating Revenue
5. Early Stage VC (Series A) 20-Dec-2023 Completed Generating Revenue
4. Seed Round 01-Jan-2023 Completed Generating Revenue
3. Accelerator/Incubator Completed Startup
2. Accelerator/Incubator 01-Apr-2022 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Talos (Decision/Risk Analysis)’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Talos (Decision/Risk Analysis) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Talos (Decision/Risk Analysis) Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Digital Healthcare Partners Accelerator/Incubator
Bridge Alliance Partners Venture Capital Minority
Medinno Partners Venture Capital Minority
Premier Partners PE/Buyout Minority
Medytox Venture Investment Corporate Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Talos (Decision/Risk Analysis) FAQs

  • When was Talos (Decision/Risk Analysis) founded?

    Talos (Decision/Risk Analysis) was founded in 2021.

  • Where is Talos (Decision/Risk Analysis) headquartered?

    Talos (Decision/Risk Analysis) is headquartered in Seoul, South Korea.

  • What is the size of Talos (Decision/Risk Analysis)?

    Talos (Decision/Risk Analysis) has 9 total employees.

  • What industry is Talos (Decision/Risk Analysis) in?

    Talos (Decision/Risk Analysis)’s primary industry is Decision/Risk Analysis.

  • Is Talos (Decision/Risk Analysis) a private or public company?

    Talos (Decision/Risk Analysis) is a Private company.

  • What is Talos (Decision/Risk Analysis)’s current revenue?

    The current revenue for Talos (Decision/Risk Analysis) is .

  • How much funding has Talos (Decision/Risk Analysis) raised over time?

    Talos (Decision/Risk Analysis) has raised $2.9M.

  • Who are Talos (Decision/Risk Analysis)’s investors?

    Digital Healthcare Partners, Bridge Alliance Partners, Medinno Partners, Premier Partners, and Medytox Venture Investment are 5 of 9 investors who have invested in Talos (Decision/Risk Analysis).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process